Sponsored Seminar
Day 1, Thursday, February 22
Medical Seminar1 February 22（Thu.）12:35～13:25
Onsite
MeS1
Room1（Century Hall, 2F, Bldg.1）
| Chair： | Eishi Baba | （Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University） |
|---|---|---|
| Speaker： | Hiroshi Kagamu | （Saitama Medical University International Medical Center Professor of Saitama Medical University International Medical Center） |
| The Past, Present, and Future of Cancer Immunotherapy “Tracing the Journey from OpdivoApproval“ | ||
- Co-host：
- Bristol-Myers Squibb K.K.／ONO PHARMACEUTICAL CO., LTD.
Medical Seminar2 February 22（Thu.）12:35～13:25
Onsite
MeS2
Room2（Reception Hall, 4F, Bldg.1）
| Chair： | Junji Tsurutani | （Advanced Cancer Translational Research Institute, Showa University） |
|---|---|---|
| Speaker： | Giuseppe Curigliano | （Department of Oncology and Hemato-Oncology University of Milano Division of Early Drug Development for Innovative Therapies European Institute of Oncology, IRCCS） |
| Treatment Strategies for HER2 positive and HER2 low Metastatic Recurrent Breast Cancer: Activity and adverse event management | ||
- Co-host：
- DAIICHI SANKYO COMPANY, LIMITED
Medical Seminar3 February 22（Thu.）12:35～13:25
Onsite
MeS3
Room3（Conference Rooms 141+142, 4F, Bldg.1）
The latest topics on the treatment for HCC
| Chair： | Masafumi Ikeda | （Department of Hepatobiliary and Pancreatic Oncology,National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Makoto Ueno | （Department of Gastroenterology Kanagawa Cancer Center） |
| Speaker： | Richard S. Finn | （Division of Hematology/Oncology, Director, Signal Transduction and Therapeutics Program, Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA） |
|---|---|---|
- Co-host：
- Chugai Pharmaceutical Co., Ltd.
Medical Seminar4 February 22（Thu.）12:35～13:25
Onsite＋Live
MeS4
Room4（International Conference Room, 3F, Bldg.3）
Diagnosis and treatment of cancer of unknown primary－The reason why it is necessary to communicate between pathologist and clinician－
| Chair： | Yuichi Takiguchi | （Department of Medical Oncology, Chiba University Hospital） |
|---|---|---|
| Speaker： | Toyonori Tsuzuki | （Department of Surgical Pathology, Aichi Medical University, School of Medicine） |
| Issues in pathological diagnosis of CUP and next vision | ||
| Speaker： | Kan Yonemori | （Department of Medical Oncology, National Cancer Center Hospital, Tokyo） |
|---|---|---|
| Diagnosis and treatment selection in cancer of unknown primary | ||
- Co-host：
- Bristol-Myers Squibb K.K.／ONO PHARMACEUTICAL CO., LTD.
Medical Seminar5 February 22（Thu.）12:35～13:25
Onsite
MeS5
Room5（Conference Rooms 431+432, 3F, Bldg.4）
| Chair： | Shinji Ohno | （Sagara Hopital） |
|---|---|---|
| Speaker： | Kanae Taruno | （Department of Surgery, Breast Surgical Division, Faculty of Medicine, Showa University） |
| Genetic Testing for BRCA1/2 in ordinary clinical practice: HBOC management and standard approaches to breast cancer treatment. | ||
- Co-host：
- Myriad Genetics G.K.
Medical Seminar6 February 22（Thu.）12:35～13:25
Onsite
MeS6
Room6（Conference Rooms 131+132, 3F, Bldg.1）
DCT for patient acccess ~ issues and expectation in early phase clinical trials ~
| Speaker： | Toshihiko Doi | （National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Noboru Yamamoto | （National Cancer Center Hospital） |
|---|---|---|
- Co-host：
- MICIN, Inc.
Medical Seminar7 February 22（Thu.）12:35～13:25
Onsite
MeS7
Room7（Conference Rooms 133+134, 3F, Bldg.1）
| Chair： | Narikazu Boku | （IMSUT Hospital, Institute of Medical Science, University of Tokyo Department of Oncology and General Medicine） |
|---|---|---|
| Speaker： | Kenji Okita | （Department of Surgery, Otaru Ekisaikai Hospital） |
| The Latest Strategies for Preventing CINV | ||
- Co-host：
- Taiho Pharmaceutical Co., Ltd.
Medical Seminar8 February 22（Thu.）12:35～13:25
Onsite
MeS8
Room8（Conference Room 234, 3F, Bldg.2）
Latest Topics on chemotherapy for Colorectal Cancer in 2024 ― Continuum of Care in Colorectal Cancer Treatment ―
| Chair： | Kensei Yamaguchi | （Department of Gastroenterological Chemotherapy Cancer Institute Hospital of Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Kentaro Yamazaki | （Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka） |
| Treatment strategies for drug therapy based on colorectal cancer treatment guidelines | ||
| Speaker： | Hisato Kawakami | （Department of Medical Oncology, Kindai University Faculty of Medicine） |
|---|---|---|
| Continuum of Care in Colorectal Cancer: Practice in Late-Line Treatment | ||
- Co-host：
- Taiho Pharmaceutical Co., Ltd.
Medical Seminar9 February 22（Thu.）12:35～13:25
Onsite
MeS9
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Isamu Okamoto | （Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University） |
|---|---|---|
| Speaker： | Takayasu Kurata | （Department of Thoracic Oncology, Kansai Medical University） |
| Personalized treatment strategy in the era of immunotherapy ~What about squamous cell lung cancer?~ |
||
- Co-host：
- Nippon Kayaku co., ltd
Medical Seminar10 February 22（Thu.）12:35～13:25
Onsite＋Live＋On demand
MeS10
Room10（Conference Room 224, 2F, Bldg.2）
| Chair： | Takayuki Yoshino | （Division for the Promotion of Drug and Diagnostic Development / Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Sadakatsu Ikeda | （Department of Precision Cancer Medicine / Center for Innovative Cancer Treatment, Tokyo Medical and Dental University） |
| Frontier in Precision Cancer Medicine: Focusing on Liquid Biopsy and Guardant360 CDx |
||
- Co-host：
- Guardant Health Japan Corp.
Medical Seminar11 February 22（Thu.）12:35～13:25
Onsite
MeS11
Room11（Conference Room 221, 2F, Bldg.2）
Onco-Cardiology Update -Appropriate Treatment and Collaboration-
| Chair： | Yukari Tsubata | （Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine） |
|---|---|---|
| Speaker： | Yuji Nishimoto | （Division of Cardiology, Osaka General Medical Center） |
| The Current Issues and Future Perspective of Cancer-Associated Thromboembolism | ||
| Speaker： | Yuji Okura | （Department of Onco-cardiology, Niigata Cancer Center Hospital.） |
|---|---|---|
| Collaboration between oncologists and cardiologists in cancer care | ||
- Co-host：
- Medical Affairs, Pfizer Japan Inc.
Medical Seminar12 February 22（Thu.）12:35～13:25
Onsite
MeS12
Room12（Conference Rooms 222+223, 2F, Bldg.2）
| Chair： | Noriko Yanagitani | （Department of Thoracic Medical Oncology, Cancer Institute Hospital） |
|---|---|---|
| Speaker： | Haruyasu Murakami | （Chemotherapy Center/Division of Thoracic Oncology, Shizuoka Cancer Center） |
| Treatment Strategies for Brain Metastases in Non-Small Cell Lung Cancer | ||
- Co-host：
- Takeda Pharmaceutical Company Limited
Medical Seminar13 February 22（Thu.）12:35～13:25
Onsite
MeS13
Room13（Exhibition Room 211, 1F, Bldg.2）
| Chair： | Nobuyuki Yamamoto | （Internal Medicine III, Wakayama Medical University） |
|---|---|---|
| Speaker： | Hiroshige Yoshioka | （Department of Thoracic Oncology,Kansai Medical University） |
| Treatment Strategies in EGFR Mutation-Positive NSCLC ~Rethinking the Use of Immune Checkpoint Inhibitors~ |
||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Evening Seminar1 February 22（Thu.）18:20～19:10
Onsite
ES1
Room1（Century Hall, 2F, Bldg.1）
| Chair： | Makoto Ueno | （Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center） |
|---|---|---|
| Speaker： | Kenji Ikezawa | （Hepatobiliary and Pancreatic Oncology / Pancreas Cancer Center, Osaka International Cancer Institute） |
| BRCA1/2 genetic testing to guide optimal treatment strategy for patients with pancreatic cancer. | ||
- Co-host：
- Myriad Genetics G.K.
Evening Seminar2 February 22（Thu.）18:20～19:10
Onsite＋Live
ES2
Room2（Reception Hall, 4F, Bldg.1）
Clinical trial over 1,500 patients Real World data, thinking about the best treatment strategy for advanced EGFRmNSCLC
| Chair： | Satoshi Oizumi | （Department of Respiratory medicine, NHO Hokkaido Cancer Center） |
|---|---|---|
| Speaker： | Yukari Tsubata | （Division of Medical Oncology and Respiratory Medicine, Shimane University） |
| Speaker： | Pasi A. Jänne | （Lowe Center for Thoracic Oncology Professor of Medicine, Harvard Medical School David M. Livingston, M.D. Chair Director, Belfer Center for Applied Cancer Science Dana Farber Cancer Institute） |
|---|---|---|
- Co-host：
- AstraZeneca K.K.
Evening Seminar3 February 22（Thu.）18:20～19:10
Onsite＋Live
ES3
Room3（Conference Rooms 141+142, 4F, Bldg.1）
| Chair： | Fumikata Hara | （Breast Medical Oncology, Japanese Foundation for Cancer Research Cancer Institute Hospital） |
|---|---|---|
| Speaker： | Sibylle Loibl | （German Breast Group, Goethe University Frankfurt/M, GBG Forschungs GmbH） |
| Recent Advances in the Treatment of Triple-Negative Breast Cancer | ||
- Co-host：
- MSD K.K.
Evening Seminar4 February 22（Thu.）18:20～19:10
Onsite＋Live
ES4
Room4（International Conference Room, 3F, Bldg.3）
Current status and challenges of Patient and Public Involvement in Europe and Japan
| Chair： | Naomi Sakurai | （Cancer Survivors Recruiting project） |
|---|---|---|
| Speaker： | Neil Bertelsen | （Patient Focused Medicines Development） |
- Co-host：
- Pfizer Japan Inc.
Evening Seminar5 February 22（Thu.）18:20～19:10
Onsite＋Live
ES5
Room5（Conference Rooms 431+432, 3F, Bldg.4）
Prospects for Comprehensive Genomic Profiling test for Cancer and Recent advances in genomic analysis of GI cancers
| Chair： | Yu Sunakawa | （Department of Clinical Oncology St. Marianna University School of Medicine） |
|---|---|---|
| Speaker： | Hiroshi Nishihara | （Genomics Unit, Keio Cancer Center, Keio University School of Medicine） |
| Comprehensive Genomic Profiling test for Cancer; Up to Date | ||
| Speaker： | Tatsuhiro Shibata | （Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo） |
|---|---|---|
| Recent advances in genomic analysis of GI cancers (focusing on biliary tract cancers) | ||
- Co-host：
- Incyte Biosciences Japan G.K.
Evening Seminar6 February 22（Thu.）18:20～19:10
Onsite＋Live
ES6
Room6（Conference Rooms 131+132, 3F, Bldg.1）
Current Issues and Future Prospects in Comprehensive Genomic Profiling Test
| Chair： | Chikashi Ishioka | （Department of Clinical Oncology, Tohoku University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Kuniko Sunami | （Department of Laboratory Medicine, National Cancer Center Hospital） |
| Practice of comprehensive genomic profiling test as health insurance in Japan. | ||
| Speaker： | Takafumi Koyama | （Department of Experimental Therapeutics, National Cancer Center Hospital） |
|---|---|---|
| The coming future of precision oncology. | ||
- Co-host：
- KONICA MINOLTA REALM, INC.
Evening Seminar7 February 22（Thu.）18:20～19:10
Onsite＋Live
ES7
Room7（Conference Rooms 133+134, 3F, Bldg.1）
| Chair： | Hidetoshi Hayashi | （Department of Medical Oncology, Kindai University Faculty of Medicine） |
|---|---|---|
| Speaker： | Koichi Azuma | （Division of Respirology, Neurology, and Rheumatology, Kurume University） |
| The Two Sides of Immunotherapies: The Balance Between Efficacy & Safety | ||
- Co-host：
- MSD K.K.
Evening Seminar8 February 22（Thu.）18:20～19:10
Onsite
ES8
Room8（Conference Room 234, 3F, Bldg.2）
| Chair： | Akihito Tsuji | （Department of Clinical Oncology Faculty of Medicine, Kagawa University） |
|---|---|---|
| Speaker： | Hiroya Taniguchi | （Department of Clinical Oncology,Aichi Cancer Center Hospital） |
| Overcoming Challenges in Driver Mutation-Positive Colorectal Cancer: Insights and Solutions | ||
- Co-host：
- ONO PHARMACEUTICAL CO., LTD.
Evening Seminar9 February 22（Thu.）18:20～19:10
Onsite＋Live
ES9
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Koichi Goto | （Department of Thoracic Oncology, National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Satoru Miura | （Department of Internal Medicine, Niigata Cancer Center Hospital） |
| New Wave for Diagnosis and Treatment in Driver-positive NSCLC patients | ||
| Speaker： | Takashi Seto | （Department Thoracic Oncology, NHO Kyushu Cancer Center） |
|---|---|---|
| Challenge for Rare driver mutation "BRAF or MET" positive NSCLC-from Clinical trial and Real world data- | ||
- Co-host：
- Novartis Pharma K.K.
Evening Seminar10 February 22（Thu.）18:20～19:10
Onsite
ES10
Room10（Conference Room 224, 2F, Bldg.2）
Drug Resistance Mechanisms in Lung Cancer
| Chair： | Hidehito Horinouchi | （Department of Thoracic Oncology, National Cancer Center Hospital） |
|---|---|---|
| Speaker： | Ryohei Katayama | （Division of Experimental Chemotherapy, Cancer Chemotherapy, JFCR） |
| Elucidation of drug resistance mechanisms using fresh samples from cancer patients | ||
| Speaker： | Tatsuya Yoshida | （Department of Thoracic Oncology, National Cancer Center Hospital） |
|---|---|---|
| The Next Move in NSCLC treatment : Opening doors to drug resistance treatments | ||
- Co-host：
- Merck Biopharma Co., Ltd.
Evening Seminar11 February 22（Thu.）18:20～19:10
Onsite
ES11
Room11（Conference Room 221, 2F, Bldg.2）
| Chair： | Akihiko Shimomura | （Dept. of Breast and Medical Oncology/Dept. of General Medical Oncology, National Center for Global Health and Medicine） |
|---|---|---|
| Speaker： | Kazuki Nozawa | （Department of Center for Cancer Genomics and Advanced Therapeutics, Breast Oncology, Aichi Cancer Center Hospital） |
| Considering FN Management in Cancer Chemotherapy - Key Points of Guideline Revision and Expectations for G-Lasta BodyPod | ||
- Co-host：
- Kyowa Kirin Co., Ltd.
Evening Seminar12 February 22（Thu.）18:20～19:10
Onsite＋Live
ES12
Room12（Conference Rooms 222+223, 2F, Bldg.2）
The Dawn of Precision Medicine in BRAF Mutation-Positive Solid Tumors
| Chair： | Ichiro Kinoshita | （Division of Clinical Cancer Genomics, Hokkaido University Hospital） |
|---|---|---|
| Speaker： | Kan Yonemori | （Department of Medical Oncology, National Cancer Center Hospital） |
| Precision Medicine in BRAF mutation-positive solid tumors across organs | ||
| Speaker： | Makoto Tahara | （Department of Head and Neck Medical Oncology, National Cancer Center Hospital East） |
|---|---|---|
| Precision Medicine in BRAF mutated Thyroid Cancer | ||
- Co-host：
- Novartis Pharma K.K.
Evening Seminar13 February 22（Thu.）18:20～19:10
Onsite
ES13
Room13（Exhibition Room 211, 1F, Bldg.2）
| Chair： | Masafumi Inomata | （OITA University Faculty of Medicine, Department of Gastroenterological and Pediatric Surgery） |
|---|---|---|
| Speaker： | Yohei Kono | （Department of Advanced Medical Research and Development for Cancer and Hair [Aderans], OITA University Faculty of Medicine） |
| Supporting Cancer Patients' Appearance : Exploring the Optimal Approach to Chemotherapy-Induced Alopecia | ||
- Co-host：
- Aderans Co.,Ltd.
Day 2, Friday, February 23
Morning Seminar1 February 23（Fri.）7:20～8:10
Onsite＋Live
MoS1
Room2（Reception Hall, 4F, Bldg.1）
ES-SCLC treatment - A pursuit: Long-term survival & lung condition -
| Chair： | Eisaku Miyauchi | （Department of Respiratory Medicine, Tohoku University Hospital） |
|---|---|---|
| Speaker： | Courtney D. DiNardo | （Internal Medicine III, Wakayama Medical University） |
- Co-host：
- AstraZeneca K.K.
Morning Seminar2 February 23（Fri.）7:20～8:10
Onsite
MoS2
Room3（Conference Rooms 141+142, 4F, Bldg.1）
| Chair： | Kosei Hasegawa | （Department of Gynecologic Oncology , Saitama Medical University International Medical Center） |
|---|---|---|
| Speaker： | Domenica Lorusso | （Obstetrics and Gynecology, Humanitas University, Rozzano (Milan), Italy / Clinical Research Developent Unit, Fondazione Policlinico “A. Gemelli” IRCCS, Rome,Italy） |
| Cutting Edge Treatments for Gynecologic Cancer | ||
- Co-host：
- MSD K.K.
Morning Seminar3 February 23（Fri.）7:20～8:10
Onsite
MoS3
Room4（International Conference Room, 3F, Bldg.3）
| Chair： | Kazuki Nozawa | （Department of Center for Cancer Genomics and Advanced Therapeutics, Breast Oncology, Aichi Cancer Center Hospital） |
|---|---|---|
| Speaker： | Aleix Prat | （Hospital Clínic Barcelona） |
| Development of novel treatment strategy for HER2 Positive Breast Cancer - HER2DX assay - | ||
| Speaker： | Sandra M. Swain | （Georgetown University Medical Center, Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC USA） |
|---|---|---|
| The latest treatment strategies in HER2 Positive Breast Cancer | ||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Morning Seminar4 February 23（Fri.）7:20～8:10
Onsite＋Live
MoS4
Room5（Conference Rooms 431+432, 3F, Bldg.4）
| Chair： | Manabu Muto | （Department of Therapeutic Oncology at the Graduate School of Medicine, Kyoto University） |
|---|---|---|
| Speaker： | Kei Muro | （Department of Clinical Oncology, Aichi Cancer Center Hospital） |
| Pharmacotherapy in Esophageal Cancer - Optimal treatment strategy for long-term survival- | ||
- Co-host：
- ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.
Morning Seminar5 February 23（Fri.）7:20～8:10
Onsite
MoS5
Room6（Conference Rooms 131+132, 3F, Bldg.1）
| Chair： | Hitoshi Kiyoi | （Department of Hematology and Oncology, Nagoya University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Mark Levis | （Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center） |
| Novel therapeutic strategies with FLT3 inhibitors in AML | ||
- Co-host：
- Astellas Pharma Inc.
Morning Seminar6 February 23（Fri.）7:20～8:10
Onsite
MoS6
Room7（Conference Rooms 133+134, 3F, Bldg.1）
| Chair： | Wataru Ichikawa | （Showa University Fujigaoka Hospital Medical Department of Medical Oncology） |
|---|---|---|
| Speaker： | Hiroki Hara | （Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan） |
| Practical perspectives on matched targeted therapy for advanced gastric cancer | ||
- Co-host：
- DAIICHI SANKYO COMPANY, LIMITED
Morning Seminar7 February 23（Fri.）7:20～8:10
Onsite
MoS7
Room8（Conference Room 234, 3F, Bldg.2）
| Chair： | Yoshito Komatsu | （Hokkaido University Hospital Tumor Center Chemotherapy Department/CancerBoard Department Director/Professor） |
|---|---|---|
| Speaker： | Akihito Tsuji | （Department of Clinical Oncology Faculty of Medicine, Kagawa University） |
| Supportive and Palliative Therapies to Accomplish Cancer Treatment | ||
- Co-host：
- Nippon Zoki Pharmaceutical Co., Ltd.
Morning Seminar8 February 23（Fri.）7:20～8:10
Onsite＋Live
MoS8
Room9（Conference Rooms 232+233, 3F, Bldg.2）
Multidisciplinary treatment approach of colorectal cancer based on the latest evidence in 2024
| Chair： | Eiji Oki | （Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University） |
|---|---|---|
| Speaker： | Jun Watanabe | （Gastroenterological Center, Yokohama City University Medical Center） |
| State-of-the-art perioperative treatment evidence for colorectal cancer in 2024 | ||
| Speaker： | Hironaga Satake | （Department of Medical Oncology, Kochi Medical School） |
|---|---|---|
| State-of-the-art colorectal cancer chemotherapy in 2024 | ||
- Co-host：
- Sanofi K.K.
Morning Seminar9 February 23（Fri.）7:20～8:10
Onsite
MoS9
Room10（Conference Room 224, 2F, Bldg.2）
| Chair： | Makoto Ueno | （Kanagawa Cancer Center, Gastroenterology） |
|---|---|---|
| Speaker： | Satoshi Kobayashi | （Kanagawa Cancer Center, Gastroenterology） |
| Comprehensive genomic profiling of BTC | ||
- Co-host：
- Nippon Boehringer Ingelheim Co., Ltd. Medicine Division
Morning Seminar10 February 23（Fri.）7:20～8:10
Onsite
MoS10
Room11（Conference Room 221, 2F, Bldg.2）
Treatment Sequencing Strategies in EGFR mutant NSCLC ~Statistical ＆ clinical viewpoint~
| Chair： | Takashi Seto | （National Hospital Organization Kyusyu Cancer Center） |
|---|---|---|
| Speaker： | Kazuhiko Nakagawa | （Kindai University Hospital） |
| Clinical Part | ||
| Speaker： | Satoshi Morita | （Kyoto University Graduate school of Medicine） |
|---|---|---|
| Statistical Part | ||
- Co-host：
- Eli Lilly Japan K.K.
Morning Seminar11 February 23（Fri.）7:20～8:10
Onsite＋Live＋On demand
MoS11
Room12（Conference Rooms 222+223, 2F, Bldg.2）
NET Update – current status and future perspective -
| Chair： | Masafumi Ikeda | （Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Izumi Ohno | （Department of Medical Oncology/Cancer Genomics Center, Chiba University Hospital） |
| PRRT paves the way for a novel era in NEN clinics - A network strategy proposed by a hospital without it’s frameworks - |
||
| Speaker： | Satoshi Takeuchi | （Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University） |
|---|---|---|
| Current positioning and future prospects of PRRT | ||
- Co-host：
- Novartis Pharma K.K.
Morning Seminar12 February 23（Fri.）7:20～8:10
Onsite
MoS12
Room13（Exhibition Room 211, 1F, Bldg.2）
| Chair： | Makoto Nishio | （Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Yoshitaka Zenke | （Department of Thoracic Oncology, National Cancer Center Hospital East） |
| ICI + Chemotherapy in elderly patients with Lung Cancer | ||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Medical Seminar14 February 23（Fri.）12:25～13:15
Onsite＋Live
MeS14
Room1
| Speaker： | Naoki Niikura | （Tokai University） |
|---|---|---|
| Luminal advanced breast cancer treatment - the latest findings and future prospects - | ||
- Co-host：
- AstraZeneca K.K.
Medical Seminar15 February 23（Fri.）12:25～13:15
Onsite
MeS15
Room2（Reception Hall, 4F, Bldg.1）
| Chair： | Noriomi Matsumura | （Kindai University, Faculty of Medicine Department of Obstetrics and Gynecology） |
|---|---|---|
| Speaker： | Kathleen N. Moore | （Stephenson Cancer Center at the University of Oklahoma HSC） |
| Expanding treatment paradigms in front line ovarian cancer | ||
- Co-host：
- AstraZeneca K.K. / MSD
Medical Seminar16 February 23（Fri.）12:25～13:15
Onsite
MeS16
Room3（Conference Rooms 141+142, 4F, Bldg.1）
| Chair： | Takayuki Yoshino | （Division for the Promotion of Drug and Diagnostic Development / Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan） |
|---|---|---|
| Speaker： | Timothy Price | （Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.） |
| The Journey and Future of Precision Medicine in Colorectal Cancer | ||
- Co-host：
- Amgen K.K.
Medical Seminar17 February 23（Fri.）12:25～13:15
Onsite
MeS17
Room4（International Conference Room, 3F, Bldg.3）
| Chair： | Kensei Yamaguchi | （Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Ian Chau | （The Royal Marsden Hospital, Sutton, UK.） |
| The future direction of the treatment sequence in Advanced Gastric Cancer | ||
- Co-host：
- Eli Lilly Japan K.K.
Medical Seminar18 February 23（Fri.）12:25～13:15
Onsite＋Live＋On demand
MeS18
Room5（Conference Rooms 431+432, 3F, Bldg.4）
How to Genome in Pancreatic and Biliary Tract Cancers.
| Chair： | Junji Furuse | （Kanagawa Cancer Center） |
|---|---|---|
| Speaker： | Masashi Kanai | （Cancer Treatment Center, Kansai Medical University Hospital） |
| The Cutting-Edge of Cancer Genomic Medicine in Pancreatic and Biliary Tract Cancers | ||
| Speaker： | Kazunaga Ishigaki | （Department of clinical oncology, The University of Tokyo） |
|---|---|---|
| Real World Data and Panel Selection Points in Panel Testing for Bile-Pancreatic Cancer | ||
- Co-host：
- SYSMEX CORPORATION
Medical Seminar19 February 23（Fri.）12:25～13:15
Onsite
MeS19
Room6（Conference Rooms 131+132, 3F, Bldg.1）
| Chair： | Yosuke Minami | （National Cancer Center Hospital East, Department of Hematology） |
|---|---|---|
| Speaker： | Courtney D. DiNardo | （Department of Leukemia, University of Texas MD Anderson Cancer Center） |
| Summary of the current treatment of AML | ||
- Co-host：
- Nippon Shinyaku Co., Ltd.
Medical Seminar20 February 23（Fri.）12:25～13:15
Onsite
MeS20
Room7（Conference Rooms 133+134, 3F, Bldg.1）
Is lorlatinib a game changer in the first-line treatment for ALK-positive NSCLC? ~What is the best treatment option for patients?
| Chair： | Naoyuki Nogami | （Department of Community Medicine, Pulmonology and Cardiology, Ehime University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Takehito Shukuya | （Department of Respiratory Medicine, Juntendo University Graduate School of Medicine） |
| How will the results of CROWN trial change the primary treatment of ALK-positive lung cancer? | ||
| Speaker： | Akito Hata | （Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center） |
|---|---|---|
| Practice of Shared Decision Making for ALK-positive lung cancer patients | ||
- Co-host：
- Pfizer Japan Inc.
Medical Seminar21 February 23（Fri.）12:25～13:15
Onsite＋Live
MeS21
Room8（Conference Room 234, 3F, Bldg.2）
Advancements of Treatment in EGFR+ NSCLC
| Chair： | Hiroshi Kagamu | （Department of Respiratory Medicine, Saitama Medical University International Medical Center） |
|---|---|---|
| Speaker： | Yukari Tsubata | （Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine） |
| The frontiers of EGFR-mutated NSCLC treatment and unmet medical needs | ||
| Speaker： | Masahiro Yasunaga | （Division of Developmental Therapeutics, National Cancer Center） |
|---|---|---|
| Diversifying antibody drugs and the relevant research progress in DDS | ||
- Co-host：
- Janssen Pharmaceutical K.K. Medical Affairs
Medical Seminar22 February 23（Fri.）12:25～13:15
Onsite
MeS22
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Eishi Baba | （Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University） |
|---|---|---|
| Speaker： | Yu Sunakawa | （St. Marianna University School of Medicine, Department of Clinical Oncology） |
| Clinical implementation and perspective of CGP testing in gastric and colorectal cancer | ||
| Speaker： | Junichi Matsubara | （Department of Clinical Oncology, Kyoto University Hospital） |
|---|---|---|
| What do we expect from CGP tests in biliary tract and pancreatic cancers? | ||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Medical Seminar23 February 23（Fri.）12:25～13:15
Onsite
MeS23
Room10（Conference Room 224, 2F, Bldg.2）
| Chair： | Shigehira Saji | （Department of Medical Oncology, Fukushima Medical University） |
|---|---|---|
| Speaker： | Sung-Bae Kim | （Asan Medical Center, University of Ulsan College of Medicine） |
| Current treatment landscape of HR+HER2- advanced breast cancer | ||
- Co-host：
- Pfizer Japan Inc.
Medical Seminar24 February 23（Fri.）12:25～13:15
Onsite＋Live
MeS24
Room11（Conference Room 221, 2F, Bldg.2）
Key updates of perioperative and advanced NSCLC treatment
| Chair： | Makoto Nishio | （Thoracic Center, Department Director, Thoracic Medical Oncology Department, The Cancer Institute Hospital of JFCR） |
|---|---|---|
| Speaker： | Yasuhiro Tsutani | （Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine） |
| Update of treatment strategy for perioperative NSCLC | ||
| Speaker： | Takayasu Kurata | （Department of Thoracic Oncology, Kansai Medical University） |
|---|---|---|
| Current status and future perspective for treatment in advanced non-small cell lung cancer | ||
- Co-host：
- MSD K.K.
Medical Seminar25 February 23（Fri.）12:25～13:15
Onsite＋Live
MeS25
Room12（Conference Rooms 222+223, 2F, Bldg.2）
Implementation of Task Shift/Sharing - A Model for Team Medicine in Cancer Cachexia -
| Chair： | Manabu Shiozawa | （Department of Gastrointestinal. Surgery, Kanagawa Cancer Center） |
|---|---|---|
| Speaker： | Atsushi Ogura | （Gastroenterological Surgery 1, Nagoya University Hospital） |
| New value of multidisciplinary collaboration for cancer cachexia treatment | ||
| Speaker： | Yasuo Kumakura | （Department of Hospital Pharmacy, Nagoya University Graduate School of Medicine） |
|---|---|---|
| Role of Pharmacists in Multidisciplinary Care for Cancer Cachexia | ||
- Co-host：
- ONO PHARMACEUTICAL CO., LTD.
Medical Seminar26 February 23（Fri.）12:25～13:15
Onsite
MeS26
Room13（Exhibition Room 211, 1F, Bldg.2）
Personalized Lung Cancer Treatment - Aiming for Optimal Treatment of Patients
| Chair： | Nobuyuki Yamamoto | （Internal Medicine Ⅲ, Wakayama Medical University） |
|---|---|---|
| Speaker： | Satoshi Morita | （Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine） |
| Speaker： | Miyako Satouchi | （Department of Thoracic Oncology, Hyogo Cancer Center） |
|---|---|---|
- Co-host：
- Eli Lilly Japan K.K.
Evening Seminar14 February 23（Fri.）18:05～18:55
Onsite
ES14
| Chair： | Yuichiro Ohe | （Department of Thoracic Oncology, National Cancer Center Hospital） |
|---|---|---|
| Speaker： | Hidetoshi Hayashi | （Department of Medical Oncology, Faculty of Medicine, Kindai University） |
| Treatment strategy for patients with HER2 mutation+NSCLC | ||
- Co-host：
- DAIICHI SANKYO COMPANY, LIMITED
Evening Seminar15 February 23（Fri.）18:05～18:55
Onsite
ES15
Room2（Reception Hall, 4F, Bldg.1）
| Chair： | Fumikata Hara | （Japanese Foundation for Cancer Research Cancer Institute Hospital, Breast Medical Oncology） |
|---|---|---|
| Speaker： | Erika Hamilton | （Breast Cancer Research Sarah Cannon Research Institute） |
| Novel Treatments in HER-2 Driven Metastatic Breast Cancer | ||
- Co-host：
- DAIICHI SANKYO COMPANY, LIMITED
Evening Seminar16 February 23（Fri.）18:05～18:55
Onsite
ES16
Room3（Conference Rooms 141+142, 4F, Bldg.1）
Unanswered questions in CML
| Chair： | Kazuhito Yamamoto | （Aichi Cancer Center） |
|---|---|---|
| Speaker： | Jorge Eduardo Cortes | （Georgia Cancer Center at Augusta University） |
- Co-host：
- Pfizer Japan Inc.
Evening Seminar17 February 23（Fri.）18:05～18:55
Onsite
ES17
Room4（International Conference Room, 3F, Bldg.3）
| Chair： | Susumu Okano | （Department of Head and Neck Medical Oncology, National Cancer Center Hospital East） |
|---|---|---|
| Speaker： | Amanda Psyrri | （National Kapodistrian University of Athens, Chair of Medicine Attikon University Hospital, Athens, Greece） |
| Treatment landscape in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: Present status and Future Directions | ||
- Co-host：
- MSD K.K.
Evening Seminar18 February 23（Fri.）18:05～18:55
Onsite
ES18
Room5（Conference Rooms 431+432, 3F, Bldg.4）
Is drug loss in Japan caused by the drug price system?
| Chair： | Noboru Yamamoto | （Department of Experimental Therapeutics, National Cancer Center Hospital） |
|---|---|---|
| Speaker： | Takashi Yasukawa | （Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare） |
- Co-host：
- IQVIA Services Japan G.K.
Evening Seminar19 February 23（Fri.）18:05～18:55
Onsite
ES19
Room6（Conference Rooms 131+132, 3F, Bldg.1）
Drug Therapy Overview of Prostate Cancer
| Chair： | Shunsuke Akamatsu | （Department of Urology, Nagoya University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Masaki Shiota | （Department of Urology, Kyushu University Hospital） |
| Speaker： | Thomas Bartholomew Powles | （Research at Barts Cancer Institute, QMUL, London Consultant Medical Oncologist, Barts Health NHS Trust） |
|---|---|---|
- Co-host：
- Janssen Pharmaceutical K.K.
Evening Seminar20 February 23（Fri.）18:05～18:55
Onsite
ES20
Room7（Conference Rooms 133+134, 3F, Bldg.1）
| Chair： | Kentaro Yamazaki | （Division of Gastrointestinal Oncology, Shizuoka Cancer Center） |
|---|---|---|
| Speaker： | Daisuke Kotani | （Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East） |
| Biomarker-based treatment strategy for colorectal cancer | ||
- Co-host：
- Bristol-Myers Squibb K.K.／ONO PHARMACEUTICAL CO., LTD.
Evening Seminar21 February 23（Fri.）18:05～18:55
Onsite＋Live
ES21
Room8（Conference Room 234, 3F, Bldg.2）
| Chair： | Kana Miyazaki | （Department of Hematology and Oncology, Mie University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Kazuyuki Shimada | （Department of Hematology, Nagoya University Hospital） |
| Current achievement and future perspectives in follicular lymphoma | ||
- Co-host：
- Chugai Pharmaceutical Co., Ltd./Nippon Shinyaku Co., Ltd
Evening Seminar22 February 23（Fri.）18:05～18:55
Onsite＋Live＋On demand
ES22
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Miyako Satouchi | （Hyogo Cancer Center Thoracic Oncology） |
|---|---|---|
| Speaker： | Ken Uchibori | （Cancer Institute Hospital of JFCR Thoracic Center） |
| Review for the growth potential of NGS multiplex gene assay | ||
- Co-host：
- Thermo Fisher Scientific
Evening Seminar23 February 23（Fri.）18:05～18:55
Onsite
ES23
Room10（Conference Room 224, 2F, Bldg.2）
| Chair： | Ken Kato | （Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital） |
|---|---|---|
| Speaker： | Hiroki Hara | （Department of Gastroenterology, Saitama Cancer Center） |
| Current status and future perspective of Keytruda for the treatment of esophageal cancer | ||
- Co-host：
- MSD K.K.
Evening Seminar24 February 23（Fri.）18:05～18:55
Onsite
ES24
Room11（Conference Room 221, 2F, Bldg.2）
Challenges of SCLC treatment, immunotherapy and the management of adverse events
| Chair： | Makoto Nishio | （Thoracic Center; Thoracic Medical Oncology Department, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Tatsuya Yoshida | （Department of Thoracic Oncology, and Department of Experimental Therapeutics, National Cancer Center Hospital） |
| Progress in immunotherapy based on tumor microenvironment analysis in SCLC | ||
| Speaker： | Wataru Munakata | （Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.） |
|---|---|---|
| Management of adverse events in cancer immunotherapy in practical clinical settings | ||
- Co-host：
- Amgen K.K.
Evening Seminar25 February 23（Fri.）18:05～18:55
Onsite
ES25
Room12（Conference Rooms 222+223, 2F, Bldg.2）
| Chair： | Hiroaki Kobayashi | （Department of Obstetrics & Gynecology, Kagoshima University） |
|---|---|---|
| Speaker： | Nozomu Yanaihara | （Department of Obstetrics and Gynecology, The Jikei University School of Medicine） |
| Current Topics in Ovarian Cancer Treatment | ||
- Co-host：
- Myriad Genetics G.K.
Evening Seminar26 February 23（Fri.）18:05～18:55
Onsite
ES26
Room13（Exhibition Room 211, 1F, Bldg.2）
| Chair： | Manabu Muto | （Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Makoto Tahara | （Department of Head and Neck Medical Oncology, National Cancer Center Hospital East） |
| Strategies of Cancer genomics for H&N Cancers | ||
- Co-host：
- Bayer Yakuhin, Ltd.
Day 3, Saturday, February 24
Morning Seminar13 February 24（Sat.）7:20～8:10
Onsite
MoS13
Room2（Reception Hall, 4F, Bldg.1）
| Chair： | Shigehira Saji | （Department of Medical Oncology, Fukushima Medical University） |
|---|---|---|
| Speaker： | Toshimi Takano | （Breast Medical Oncology Drpartment, Breast Oncology Center, Cancer Institute Hospital） |
| Concept of perioperative drug therapy for HR-positive HER2-negative breast cancer | ||
- Co-host：
- Exact Sciences
Morning Seminar14 February 24（Sat.）7:20～8:10
Onsite
MoS14
Room3（Conference Rooms 141+142, 4F, Bldg.1）
Appearance Care and Issues facing Patients with Cancer
| Chair： | Jiichiro Sasaki | （Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine） |
|---|---|---|
| Chair： | Naomi Sakurai | （Cancer Survivors Recruiting project） |
| Speaker： | Keiko Nozawa | （Department of Nursing, Faculty of Nursing, Mejiro University） |
| How to approach patients suffering from skin changes | ||
- Co-host：
- Kirin Holdings Company, Limited／Kyowa Kirin Co., Ltd.／FANCL CORPORATION
Morning Seminar15 February 24（Sat.）7:20～8:10
Onsite
MoS15
Room4（International Conference Room, 3F, Bldg.3）
| Chair： | Shunji Takahashi | （Department of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Makoto Tahara | （Department of Head and Neck Cancer Oncology, National Cancer Center Hospital East） |
| A treatment strategy aimed at maximizing the therapeutic effects of lenvatinib derived from 13 years of experience in use | ||
- Co-host：
- Eisai Co.,Ltd.
Morning Seminar16 February 24（Sat.）7:20～8:10
Onsite＋Live
MoS16
Room5（Conference Rooms 431+432, 3F, Bldg.4）
| Chair： | Nobuhiko Seki | （Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine） |
|---|---|---|
| Speaker： | Akito Hata | （Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center） |
| Treatment Strategy for EGFR-Mutant Lung Cancer ～Focusing on Potential of Afatinib-Osimertinib Sequence Therapy～ | ||
- Co-host：
- Nippon Boehringer Ingelheim Co., Ltd.
Morning Seminar17 February 24（Sat.）7:20～8:10
Onsite＋Live＋On demand
MoS17
Room6（Conference Rooms 131+132, 3F, Bldg.1）
The diagnosis of bone metastasis in CT follow-up exam supported by the temporal subtraction
| Chair： | Hiroyuki Shibata | （Department of Clinical Oncology, Akita University Graduate School of Medicine） |
|---|---|---|
| Speaker： | Ryo Sakamoto | （Department of Real World Data R & D, Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University） |
| Diagnosis of Bone Metastases Utilizing Temporal Subtraction of Bone in Follow-up CT ~ Development and experience of "Temporal Subtraction For Bone®"~ | ||
| Speaker： | Fumihiko Nakatani | （Musculoskeletal Surgery, National Cancer Center Hospital East） |
|---|---|---|
| Support Technologies for Metastatic Spinal Tumors using Temporal CT Image Subtraction. | ||
- Co-host：
- CANON MEDICAL SYSTEMS CORPORATION
Morning Seminar18 February 24（Sat.）7:20～8:10
Onsite＋Live
MoS18
Room7（Conference Rooms 133+134, 3F, Bldg.1）
| Chair： | Kazuhito Yamamoto | （Aichi Cancer Center） |
|---|---|---|
| Speaker： | Naoto Kawabe | （Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine） |
| Reactivation of Hepatitis B Virus Caused by Chemotherapy and Immunosuppressive Therapy - Prevention of Acute Liver Failure - |
||
- Co-host：
- Gilead Sciences K.K. Medical Affairs
Morning Seminar19 February 24（Sat.）7:20～8:10
Onsite
MoS19
Room8（Conference Room 234, 3F, Bldg.2）
Optimization of the lung cancer genetic testing: Insight from an Advanced Medicine A trial using MINtS
| Chair： | Koichi Hagiwara | （Jichi Medical University） |
|---|---|---|
| Speaker： | Masayuki Nakayama | （Division of Pulmonary Medicine, Department of Internal Medicine, Jichi Medical University） |
| Part1. From the perspective of specimen collection in bronchoscopy examinations | ||
| Speaker： | Masanori Kawakami | （Department of Respiratory Medicine, The University of Tokyo Hospital） |
|---|---|---|
| Part2. From the perspective of selecting genetic testing methods | ||
- Co-host：
- EIKEN CHEMICAL CO.,LTD.
Morning Seminar20 February 24（Sat.）7:20～8:10
Onsite＋Live
MoS20
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Masato Ozaka | （Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research） |
|---|---|---|
| Speaker： | Akihiro Ohba | （Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital） |
| Treatment strategies for unresectable pancreatic cancer based on the latest clinical trial results | ||
- Co-host：
- NIHON SERVIER CO., LTD.
Morning Seminar21 February 24（Sat.）7:20～8:10
Onsite＋Live＋On demand
MoS21
Room10（Conference Room 224, 2F, Bldg.2）
Antibody-Drug Conjugates: Shifting Paradigm in Cancer Therapy
| Chair： | Solange Peters | （Centre Hospitalier Universitaire Vaudois Lausanne） |
|---|---|---|
| Speaker： | Solange Peters | （Centre Hospitalier Universitaire Vaudois Lausanne） |
| ADCs: State of the Science and Perspectives | ||
| Speaker： | Hiroki Izumi | （National Cancer Center Hospital East） |
|---|---|---|
| ADC Therapeutic Targets: What’s Next? | ||
- Co-host：
- Seagen International GmbH／Pfizer Japan Inc.
Morning Seminar22 February 24（Sat.）7:20～8:10
Onsite
MoS22
Room11（Conference Room 221, 2F, Bldg.2）
| Chair： | Kadoaki Ohashi | （Department of Respiratory Medicine, Okayama University Hospital） |
|---|---|---|
| Speaker： | Eisaku Miyauchi | （Department of Respiratory Medicine, Tohoku University Hospital） |
| Tips for Multiplex Testing in Lung Cancer - To detect KRASG12C mutation-positive lung cancer – | ||
| Speaker： | Satoshi Ikeda | （Kanagawa Cardiovascular and Respiratory Center） |
|---|---|---|
| Sotorasib for NSCLC with KRAS G12C mutation -Ensuring the delivery of long-awaited drug to patients- | ||
- Co-host：
- Amgen K.K.
Morning Seminar23 February 24（Sat.）7:20～8:10
Onsite
MoS23
Room12（Conference Rooms 222+223, 2F, Bldg.2）
A Personalized Treatment for Multiple Myeloma Patients to Realize Well-being
| Chair： | Mitsuhiro Itagaki | （Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital） |
|---|---|---|
| Speaker： | Hitoshi Hanamoto | （Department of Hematology, Kindai University Nara Hospital） |
| Considering Well-being in Multiple Myeloma Treatment: How to Face Treatment with Satisfaction | ||
| Speaker： | Shinichi Fuchida | （Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan ） |
|---|---|---|
| Multiple Myeloma Treatment Sequencing Strategies from a Well-being Perspective | ||
- Co-host：
- Takeda pharmaceutical Company Ltd.
Morning Seminar24 February 24（Sat.）7:20～8:10
Onsite
MoS24
Room13（Exhibition Room 211, 1F, Bldg.2）
| Chair： | Kei Muro | （Department of Clinical Oncology, Aichi Cancer Center Hospital） |
|---|---|---|
| Speaker： | Eiji Shinozaki | （Department of Gastroenterological chemotherapy,Cancer Institute Hospital of the Japanese Foundation for Cancer Research） |
| Strategic Changes and Positioning of Anti-EGFR Antibodies in Colorectal Cancer Chemotherapy | ||
| Speaker： | Yu Sunakawa | （Department of Clinical Oncology, St. Marianna University School Medicine） |
|---|---|---|
| Colorectal Cancer Drug Therapy -The Latest Findings on 1st Line Therapy Options- | ||
- Co-host：
- Merck Biopharma Co., Ltd.
Medical Seminar27 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS27
Up-to-date treatment strategy for DLBCL
| Chair： | Eisei Kondo | （Department of Hematology, Kawasaki Medical School） |
|---|---|---|
| Speaker： | Dai Maruyama | （Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research） |
- Co-host：
- Genmab KK, Medical Affairs / AbbVie GK, Medical
Medical Seminar28 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS28
Room2（Reception Hall, 4F, Bldg.1）
| Chair： | Yasuaki Sagara | （Sagara Hospital） |
|---|---|---|
| Speaker： | Otto Metzger | （Dana-Farber Cancer Institute, Harvard Medical School, Alliance for Clinical Trials in Oncology） |
| BRCA1/2 related breast cancer: Insights into adjuvant therapy strategies | ||
- Co-host：
- AstraZeneca K.K.
Medical Seminar29 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS29
Room3（Conference Rooms 141+142, 4F, Bldg.1）
| Chair： | Masafumi Ikeda | （Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Japan） |
|---|---|---|
| Speaker： | Do-Youn Oh | （Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea） |
| Immunotherapy in Biliary Tract Cancer. | ||
- Co-host：
- AstraZeneca K.K.
Medical Seminar30 February 24（Sat.）12:00～12:50
Onsite
MeS30
Room4（International Conference Room, 3F, Bldg.3）
Skin disorder management with immune checkpoint inhibitors
| Chair： | Yoshio Kiyohara | （Supportive Care Center・Division of Dermatology, Shizuoka Cancer Center） |
|---|---|---|
| Speaker： | Anisha B. Patel | （Dept of Dermatology UT MD Anderson Cancer Center UT Health Science Center- Houston） |
| Charting a Path: The Algorithmic Approach to Checkpoint Inhibitor Induced Cutaneous Toxicities | ||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Medical Seminar31 February 24（Sat.）12:00～12:50
Onsite
MeS31
Room5（Conference Rooms 431+432, 3F, Bldg.4）
| Chair： | Kei Muro | （Department of Clinical Oncology, Aichi Cancer Center Hospital） |
|---|---|---|
| Speaker： | Elizabeth Smyth | （Oxford University Hospitals NHS Trust, UK） |
| Evolving benefits of immune checkpoint inhibitors in advanced gastric cancer | ||
- Co-host：
- Bristol-Myers Squibb K.K.／ONO PHARMACEUTICAL CO., LTD.
Medical Seminar32 February 24（Sat.）12:00～12:50
Onsite
MeS32
Room6（Conference Rooms 131+132, 3F, Bldg.1）
| Chair： | Shigehira Saji | （Department of Medical Oncology, Fukushima Medical University） |
|---|---|---|
| Speaker： | Kazunoshin Tachibana | （Department of Breast Surgery, Fukushima Medical University School of Medicine） |
| New approach of supportive care for changes of the cancer treatment environment: Chemotherapy- induced alopecia and scalp cooling | ||
- Co-host：
- Hair Clinic Reve-21 Co., Ltd.
Medical Seminar33 February 24（Sat.）12:00～12:50
Onsite
MeS33
Room7（Conference Rooms 133+134, 3F, Bldg.1）
The Pursuit of Personalized Medicine Unraveling from Evidence and Experience
| Chair： | Makoto Maemondo | （Division of Pulmonary Medicine Department of Medicine Jichi Medical University School of Medicine ） |
|---|---|---|
| Speaker： | Kei Kunimasa | （Department of Thoracic Oncology, Osaka International Cancer Institute） |
| Precision Medicine for Lung Cancer in Practical Need | ||
| Speaker： | Yuri Taniguchi | （Department of Respiratory Medicine, Yokohama City Citizen’s Hospital） |
|---|---|---|
| Treatment strategies for ALK-rearranged advanced NSCLC | ||
- Co-host：
- CHUGAI PHARMACEUTICAL CO., LTD.
Medical Seminar34 February 24（Sat.）12:00～12:50
Onsite
MeS34
Room8（Conference Room 234, 3F, Bldg.2）
| Chair： | Masahiro Tsuboi | （Thoracic Surgery ＆ Oncology, National Cancer Center Hospital East ） |
|---|---|---|
| Speaker： | Jonathan D. Spicer | （Mc Gill University Health Center Montreal, Quebec, Canada） |
| Checkmate 816: A turning point for a new era of care for patients with resectable NSCLC | ||
- Co-host：
- Bristol-Myers Squibb K.K.／ONO PHARMACEUTICAL CO., LTD.
Medical Seminar35 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS35
Room9（Conference Rooms 232+233, 3F, Bldg.2）
| Chair： | Junji Tsurutani | （Advanced Cancer Translational Research Institute, Showa University） |
|---|---|---|
| Speaker： | Hope S. Rugo | （University of California San Francisco Comprehensive Cancer Center） |
| Optimal treatment of patients with metastatic breast cancer: incorporating the multidisciplinary team and shared decision making |
||
- Co-host：
- Gilead Sciences K.K. Medical Affairs
Medical Seminar36 February 24（Sat.）12:00～12:50
Onsite
MeS36
Room10（Conference Room 224, 2F, Bldg.2）
| Chair： | Toshimi Takano | （Breast Oncology Center, The Cancer Institute Hospital of JFCR） |
|---|---|---|
| Speaker： | Matthew P Goetz | （Mayo Clinic） |
| New results from clinical trials in breast cancer | ||
- Co-host：
- Eli Lilly Japan K.K.
Medical Seminar37 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS37
Room11（Conference Room 221, 2F, Bldg.2）
| Chair： | Eishi Baba | （Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University） |
|---|---|---|
| Speaker： | Toshiki Masuishi | （Department of Clinical Oncology, Aichi Cancer Center Hospital） |
| Chemotherapy for Colorectal Cancer: Best Practices from the Latest Topics | ||
- Co-host：
- Takeda Pharmaceutical Company Limited
Medical Seminar38 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS38
Room12（Conference Rooms 222+223, 2F, Bldg.2）
Expectations for anti-CTLA-4 antibody "Imjudo" in lung and liver cancer
| Chair： | Hidetoshi Hayashi | （Kindai University Faculty of Medicine Department of Medical Oncology） |
|---|---|---|
| Speaker： | Goki Suda | （Department of Gastroenterology and Hepatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine） |
| Advances in immunotherapy for unresectable hepatocellular carcinoma | ||
| Speaker： | Ryo Ariyasu | （The Cancer Institute Hospital, Japanese Foundation for Cancer Research） |
|---|---|---|
| Expectations for the POSEIDON regimen in stage IV NSCLC: Thoughts based on clinical trial results and clinical experience | ||
- Co-host：
- AstraZeneca K.K.
Medical Seminar39 February 24（Sat.）12:00～12:50
Onsite＋Live
MeS39
Room13（Exhibition Room 211, 1F, Bldg.2）
Biomarkers of gastric cancer
| Chair： | Narikazu Boku | （Department of Oncology and General Medicine IMSUT Hospital, Institute of Medical Science, University of Tokyo, Japan） |
|---|---|---|
| Speaker： | Taroh Satoh | （Center for Cancer Genomics and Precision Medicine, Osaka University Hospital） |
| Targetable biomarkers for gastric cancer – From HER2 to Claudin 18.2－ | ||
- Co-host：
- Astellas Pharma Inc.